tetrazepam-mip 100 mg tabletten
tetrazepam-mip 25 mg tabletten
tetrazepam-mip 50 mg tabletten
vancomycin cnp 1000 mg pulver till infusionsvätska, lösning
vancomycin cnp 500 mg pulver till infusionsvätska, lösning
vancosan 500 mg pulver till infusionsvätska, lösning
vancosan 1000 mg pulver till infusionsvätska, lösning
glukosamin mip 400 mg filmdragerad tablett
xeloda
cheplapharm arzneimittel gmbh - capecitabine - colonic neoplasms; breast neoplasms; colorectal neoplasms; stomach neoplasms - antineoplastic agents - xeloda is indicated for the adjuvant treatment of patients following surgery of stage iii (dukes' stage c) colon cancer.xeloda is indicated for the treatment of metastatic colorectal cancer.xeloda is indicated for first-line treatment of advanced gastric cancer in combination with a platinum-based regimen.xeloda in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracycline. xeloda is also indicated as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline-containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.